Sign in
4/A

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001181431-05-003293

Director acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

McKenney Charles · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2005-01-10 Option exercise : show line 1 in the form +25,000 $1.00 $25,000 25,200 D
Loading xslF345X02/rrd64670.xml…